Vista Biologic Solutions

Vista Biologic Solutions Inc. provides specialized consulting services for the early-stage development of vaccine and therapeutic products. The firm offers strategic oversight for a variety of modalities, including mRNA-LNP, monoclonal antibodies, subunit proteins, and viral vectors. Their service suite encompasses process and analytical development, CMC regulatory support, technology transfer to contract development and manufacturing organizations (CDMOs), and technical writing. Additionally, the company provides interim leadership and due diligence services to identify risks, gaps, and inefficiencies in development programs.

These consulting services are intended to help biotechnology and biopharmaceutical organizations navigate the complexities of biologics development from early stages through to clinical trial readiness. By leveraging over two decades of industry experience, the consultancy aims to streamline the progression of therapeutic candidates, support regulatory submissions, and ensure quality by design. The company assists clients in addressing critical development milestones, such as process validation and documentation, to facilitate efficient movement into Phase 1 and 2 clinical trials.